Zoledronic acid exacerbates inflammation through M1 macrophage polarization

BACKGROUND: Zoledronic acid (Zol), one of the bisphosphonates, is frequently utilized for the treatment of osteoporosis and bone metastasis. However, the onset of medication-related osteonecrosis of the jaw (MRONJ) following dental treatments has become a serious issue. We reported previously that o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Junya, Okinaga, Toshinori, Hikiji, Hisako, Ariyoshi, Wataru, Yoshiga, Daigo, Habu, Manabu, Tominaga, Kazuhiro, Nishihara, Tatsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015454/
https://www.ncbi.nlm.nih.gov/pubmed/29977413
http://dx.doi.org/10.1186/s41232-018-0074-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015454/
https://www.ncbi.nlm.nih.gov/pubmed/29977413
http://dx.doi.org/10.1186/s41232-018-0074-9

Ejemplares similares